1999 sets the scene for change in Europe
This article was originally published in Clinica
As the old millennium drew to a close, the European regulatory arena for medical devices looked set to operate in a substantially changed environment from that of the previous decade. Significant changes are expected that could see the consolidation of regulatory powers, both at industry and Commission level.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.